Scott Kasner talks to Eivind Berge about the GORE REDUCE trial at ESOC 2017 in Prague. Established superiority of PFO closure in conjunction with antiplatelet therapy over antiplatelet therapy alone in reducing the risk of recurrent clinical ischemic stroke or new brain infarct.
Content produced and shared with kind authorisation of the European Stroke Organisation (ESO) and the European Stroke Organisation Conference (ESOC 2017).
ESOC 2017 – Scott Kasner talks about the GORE REDUCE trial
Share
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
The European Stroke Organisation Conference (ESOC) 2023 will take place 24-26 May 2023 in Munich, Germany. The conference will include sessions, plenary lectures, and symposia, covering a wide range of topics related to stroke, including acute management, rehabilitation, imaging, epidemiology, and public health. Prof. Peter Kelly (President, European Stroke Organisation, Dublin, Ireland) joins touchNEUROLOGY to […]
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
The Stroke Alliance for Europe (SAFE) is a non-profit-making organisation that represents a range of patient groups from across Europe. Their mutual goal is to drive stroke prevention up the European political agenda and prevent the incidence of stroke through ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Brain-age biomarkers can be used to predict post-stroke recovery. Dr Martin Bretzner (Lille Neuroscience & Cognition Research Centre, Lille University Hospital, Lille, France) discusses the results of a study using radiomics, an emerging image-quantifying technology to assess 'brain-age' biomarkers. The ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
The composition of the gut microbiome is a modifiable factor associated with the risk of ischaemic stroke and post-stroke neurological outcome. Dr Miquel Lledós (Stroke Pharmacogenomics and Genetics Laboratory, Sant Pau Research Institute, Barcelona, Spain) discusses the outcome of ...
Mark CompleteCompleted
BookmarkBookmarked
We had the pleasure of meeting up with Dr Johanna Ospel (University Hospital, Basel, Switzerland) to discuss the findings from the ESCAPE-NA1 Trial. The abstract entitled "Predictors and Clinical Impact of Infarct Progression Rate in the ESCAPE-NA1 Trial" was presented ...
Mark CompleteCompleted
BookmarkBookmarked
We had the pleasure of meeting up with Prof. Michael Hill (University of Calgary, Calgary, Canada) to discuss the use of nerinetide in the treatment of patients who had an acute ischaemic stroke, and the findings from the ESCAPE-NA1 trial. ...
Mark CompleteCompleted
BookmarkBookmarked
Hanne Christensen, Arlene Wilkie & Francesca Romana Pezzella: Stroke Action Plan for Europe (Part 1)
NEW
In conjunction with the European Stroke Organisation (ESO), we had the pleasure of meeting with Prof. Hanne Christensen (Chair, Stroke Action Plan for Europe), Arlene Wilkie (Co-Chair, Stroke Action Plan for Europe), and Dr Francesca Romana Pezzella (Co-Chair, Stroke Action ...
Mark CompleteCompleted
BookmarkBookmarked
Hanne Christensen, Arlene Wilkie & Francesca Romana Pezzella: Stroke Action Plan for Europe (Part 2)
NEW
In conjunction with the European Stroke Organisation (ESO), we had the pleasure of meeting with Prof. Hanne Christensen (Chair, Stroke Action Plan for Europe), Arlene Wilkie (Co-Chair, Stroke Action Plan for Europe), and Dr Francesca Romana Pezzella (Co-Chair, Stroke Action ...
Mark CompleteCompleted
BookmarkBookmarked
Vida Demarin (International Institute for Brain Health, Zagreb, Croatia) kindly took the time to speak with us on the topic of the debate session she participated in: Should statins be given to people over age 80 for stroke prevention? As co-Chair ...
Mark CompleteCompleted
BookmarkBookmarked
We were delighted to have an opportunity to hear all about the Stroke Action Plan for Europe from Arlene Wilkie, Director General of the Stroke Alliance for Europe (SAFE). Related useful resources: Stroke Alliance for Europe (SAFE) Economic Impact of ...
Mark CompleteCompleted
BookmarkBookmarked
NEW
Hans-Christoph Diener (Medical Faculty of the University of Duisburg-Essen, Institute for Medical Informatics, Biometry and Epidemiology, Essen, Germany), talks to us around the highlights of his recently published co-authored review article entitled: Patent Foramen Ovale Closure—Addressing the Unmet Need ...
Mark CompleteCompleted
BookmarkBookmarked
NEW
Anna Tancin Lambert (University of Oslo and Department of Neurology Østfold Hospital Trust, Norway) discussed with us exciting interim findings from the international, multicentre, prospective, observational Nordic Atrial Fibrillation and Stroke (NOR-FIB) study, which highlight atrial fibrillation as the hidden ...
Mark CompleteCompleted
BookmarkBookmarked
The Charles Edouard Brown-Séquard Lecture at EAN 2019 was delivered by Prof. Ulrich Dirnagl, who had a chat with EAN eCommunciations Board Co-Chair, PD DR. Tim von Oertzen about his work. Video produced by and shared with kind authorisation of ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
